Related Experiment Videos
Recognising and treating. Premalignant skin conditions
1Department of Dermatology, Royal Free Hospital, London.
The Practitioner
|September 24, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Zosteriform Kaposi's sarcoma.
Clinical and experimental dermatology·2001
Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris.
Clinical and experimental dermatology·2001
Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
European journal of immunology·2001
The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema.
Clinical and experimental immunology·2000
Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg).
Journal of the American Academy of Dermatology·2000
Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7.
Pathobiology : journal of immunopathology, molecular and cellular biology·2000
Improving pain control in diabetic neuropathy.
The Practitioner·2017
Tailor management to the patient with fibroids.
The Practitioner·2017
Preventing stroke and assessing risk in women.
The Practitioner·2017
Early referral improves long-term outcomes in rheumatoid arthritis.
The Practitioner·2017
Diagnosing and managing mild cognitive impairment.
The Practitioner·2017
Be vigilant for dementia in Parkinson’s disease.
The Practitioner·2017
US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective study.
Future oncology (London, England)·2026
Epitranscriptomic control of epithelial-mesenchymal transition in cancer: mechanisms, plasticity, and therapeutic opportunities.
Frontiers in cell and developmental biology·2026
A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support.
Frontiers in artificial intelligence·2026